„Focusing on IL-6/STAT3 Pathway shows the approach of anti-IL-6 antibody (tocilizumab) in the treatment of multiple hydrocephalus“, Current Opinion, Bd. 1, Nr. 01, S. 15–19, Dez. 2021, Zugegriffen: Okt. 11, 2026. Verfügbar unter: https://currentopinion.be/index.php/co/article/view/14